Study in Advanced Parkinson's Disease Patients With Predictable Motor Fluctuations
Status:
Completed
Trial end date:
2012-10-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to explore the efficacy and tolerability of DM-1992
compared to a standard carbidopa/Levodopa Immediate-Release (CD/LD IR) tablet (Sinemet IR) as
measured by:
- "ON" time with no dyskinesia or non-troublesome dyskinesia
- "OFF" time
Phase:
Phase 2
Details
Lead Sponsor:
Depomed
Treatments:
Carbidopa Carbidopa, levodopa drug combination Levodopa